Spanish diagnostic solutions provider STAT-Dx is set to unveil its new in-vitro diagnostics system DiagCORE at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held in Vienna, Austria, between 22 and 25 April.

DiagCORE is a fully integrated multiplex real-time polymerase chain reaction (PCR) diagnosis platform with the potential to detect approximately 48 molecular targets simultaneously in a single sample.

The multiplex real-time PCR capability makes the system ideal for complex assays from all types of clinical samples.

STAT-Dx chief executive officer Jordi Carrera said: "We are delighted to be unveiling our DiagCORE system and first respiratory panel at ECCMID.

"STAT-Dx's fast, syndromic diagnostic system is set to become a key asset in the infectious diseases diagnostic market, which is rapidly embracing innovative multiplex PCR-based technologies.

"DiagCORE's simplicity and delivery of fast actionable answers has the potential to greatly improve clinical and economic outcomes. Furthermore, with low manufacturing costs at the core of our design, we are confident on being able to bring a highly competitive product to the market."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"With low manufacturing costs at the core of our design, we are confident on being able to bring a highly competitive product to the market."

DiagCORE Respiratory Panel is the firm's first assay, with the capability to simultaneously detect and identify around 22 viral and bacterial pathogens.

The test can be used with nasopharyngeal swab samples from patients with acute respiratory symptoms.

STAT-Dx intends to commence registration trials for the respiratory panel, with plans to receive CE mark in the second half of this year.

The firm is also working on additional panels for clinical microbiology and infectious disease applications and expects to commercialise its second assay, Gastrointestinal Panel, next year.